{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:38:20Z","timestamp":1790318300212,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T00:00:00Z","timestamp":1543968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 15828"],"award-info":[{"award-number":["IG 15828"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 17048"],"award-info":[{"award-number":["IG 17048"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1038\/s41375-018-0305-8","type":"journal-article","created":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T15:19:59Z","timestamp":1544023199000},"page":"1231-1242","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K\/AKT\/mTORC1 pathway and its prognostic relevance"],"prefix":"10.1038","volume":"33","author":[{"given":"Cristina","family":"Cristofoletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Bresin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Picozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Picchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Monzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Helmer Citterich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Passarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Frezzolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Scala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Monopoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Cantonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Benucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"D\u2019Atri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Caprini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giandomenico","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Narducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,5]]},"reference":[{"key":"305_CR1","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1200\/JCO.2010.32.0630","volume":"29","author":"EA Olsen","year":"2011","unstructured":"Olsen EA, Whittaker S, Kim YH, Duvic M, Prince HM, Lessin SR, et al. Clinical end points and response criteria in mycosis fungoides and S\u00e9zary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol. 2011;29:2598\u2013607.","journal-title":"J Clin Oncol"},{"key":"305_CR2","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1200\/JCO.2015.61.7142","volume":"33","author":"JJ Scarisbrick","year":"2015","unstructured":"Scarisbrick JJ, Prince HM, Vermeer MH, Quaglino P, Horwitz S, Porcu P, et al. Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and S\u00e9zary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model. J Clin Oncol. 2015;33:3766\u201373.","journal-title":"J Clin Oncol"},{"key":"305_CR3","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","volume":"116","author":"JJ Campbell","year":"2010","unstructured":"Campbell JJ, Clark RA, Watanabe R, Kupper TS. Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors. Blood. 2010;116:767\u201371.","journal-title":"Blood"},{"key":"305_CR4","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/gcc.10152","volume":"36","author":"X Mao","year":"2003","unstructured":"Mao X, Lillington DM, Czepulkowski B, Russell-Jones R, Young BD, Whittaker S. Molecular cytogenetic characterization of S\u00e9zary syndrome. Genes, Chromosom Cancer. 2003;36:250\u201360.","journal-title":"Genes, Chromosom Cancer"},{"key":"305_CR5","doi-asserted-by":"publisher","first-page":"8438","DOI":"10.1158\/0008-5472.CAN-09-2367","volume":"69","author":"E Caprini","year":"2009","unstructured":"Caprini E, Cristofoletti C, Arcelli D, Fadda P, Citterich MH, Sampogna F, et al. Identification of key regions and genes important in the pathogenesis of sezary syndrome by combining genomic and expression microarrays. Cancer Res. 2009;69:8438\u201346.","journal-title":"Cancer Res"},{"key":"305_CR6","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1158\/0008-5472.CAN-07-6398","volume":"68","author":"MH Vermeer","year":"2008","unstructured":"Vermeer MH, van Doorn R, Dijkman R, Mao X, Whittaker S, van Voorst Vader PC, et al. Novel and highly recurrent chromosomal alterations in S\u00e9zary syndrome. Cancer Res. 2008;68:2689\u201398.","journal-title":"Cancer Res"},{"key":"305_CR7","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/ng.3356","volume":"47","author":"J Choi","year":"2015","unstructured":"Choi J, Goh G, Walradt T, Hong BS, Bunick CG, Chen K, et al. Genomic landscape of cutaneous T cell lymphoma. Nat Genet. 2015;47:1011\u20139.","journal-title":"Nat Genet"},{"key":"305_CR8","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/ng.3370","volume":"47","author":"A Ungewickell","year":"2015","unstructured":"Ungewickell A, Bhaduri A, Rios E, Reuter J, Lee CS, Mah A, et al. Genomic analysis of mycosis fungoides and S\u00e9zary syndrome identifies recurrent alterations in TNFR2. Nat Genet. 2015;47:1056\u201360.","journal-title":"Nat Genet"},{"key":"305_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9470","volume":"6","author":"MJ Kiel","year":"2015","unstructured":"Kiel MJ, Sahasrabuddhe AA, Rolland DCM, Velusamy T, Chung F, Schaller M, et al. Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in S\u00e9zary syndrome. Nat Commun. 2015;6:8470.","journal-title":"Nat Commun"},{"key":"305_CR10","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/ng.3442","volume":"47","author":"AC Silva Almeida da","year":"2015","unstructured":"da Silva Almeida AC, Abate F, Khiabanian H, Martinez-Escala E, Guitart J, Tensen CP, et al. The mutational landscape of cutaneous T cell lymphoma and S\u00e9zary syndrome. Nat Genet. 2015;47:1465\u201370.","journal-title":"Nat Genet"},{"key":"305_CR11","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1038\/ng.3444","volume":"47","author":"L Wang","year":"2015","unstructured":"Wang L, Ni X, Covington KR, Yang BY, Shiu J, Zhang X, et al. Genomic profiling of S\u00e9zary syndrome identifies alterations of key T cell signaling and differentiation genes. Nat Genet. 2015;47:1426\u201334.","journal-title":"Nat Genet"},{"key":"305_CR12","doi-asserted-by":"publisher","first-page":"39627","DOI":"10.18632\/oncotarget.17383","volume":"8","author":"K I\u017cykowska","year":"2017","unstructured":"I\u017cykowska K, Przybylski GK, Gand C, Braun FC, Grabarczyk P, Kuss AW, et al. Genetic rearrangements result in altered gene expression and novel fusion transcripts in S\u00e9zary syndrome. Oncotarget. 2017;8:39627\u201339.","journal-title":"Oncotarget"},{"key":"305_CR13","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/ajh.24876","volume":"92","author":"RA Wilcox","year":"2017","unstructured":"Wilcox RA. Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and management. Am J Hematol. 2017;92:1085\u2013102.","journal-title":"Am J Hematol"},{"key":"305_CR14","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1182\/blood-2005-03-1139","volume":"107","author":"K Yamanaka","year":"2006","unstructured":"Yamanaka K, Clark R, Rich B, Dowgiert R, Hirahara K, Hurwitz D, et al. Skin-derived interleukin-7 contributes to the proliferation of lymphocytes in cutaneous T-cell lymphoma. Blood. 2006;107:2440\u20135.","journal-title":"Blood"},{"key":"305_CR15","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1182\/blood.V99.8.2929","volume":"99","author":"CL Berger","year":"2002","unstructured":"Berger CL, Hanlon D, Kanada D, Dhodapkar M, Lombillo V, Wang N, et al. The growth of cutaneous T-cell lymphoma is stimulated by immature dendritic cells. Blood. 2002;99:2929\u201339.","journal-title":"Blood"},{"key":"305_CR16","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1182\/blood-2009-05-220111","volume":"114","author":"RA Wilcox","year":"2009","unstructured":"Wilcox RA, Wada DA, Ziesmer SC, Elsawa SF, Comfere NI, Dietz AB, et al. Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells. Blood. 2009;114:2936\u201344.","journal-title":"Blood"},{"key":"305_CR17","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1038\/jid.2014.206","volume":"134","author":"X Wu","year":"2014","unstructured":"Wu X, Schulte BC, Zhou Y, Haribhai D, Mackinnon AC, Plaza JA, et al. Depletion of M2-like tumor-associated macrophages delays cutaneous T-cell lymphoma development in vivo. J Invest Dermatol. 2014;134:2814\u201322.","journal-title":"J Invest Dermatol"},{"key":"305_CR18","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1182\/blood-2012-03-415638","volume":"120","author":"A Rabenhorst","year":"2012","unstructured":"Rabenhorst A, Schlaak M, Heukamp LC, F\u00f6rster A, Theurich S, von Bergwelt-Baildon M, et al. Mast cells play a protumorigenic role in primary cutaneous lymphoma. Blood. 2012;120:2042\u201354.","journal-title":"Blood"},{"key":"305_CR19","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1038\/onc.2015.462","volume":"35","author":"M Tesio","year":"2016","unstructured":"Tesio M, Trinquand A, Macintyre E, Asnafi V. Oncogenic PTEN functions and models in T-cell malignancies. Oncogene. 2016;35:3887\u201396.","journal-title":"Oncogene"},{"key":"305_CR20","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1182\/blood-2013-06-510578","volume":"122","author":"C Cristofoletti","year":"2013","unstructured":"Cristofoletti C, Picchio MC, Lazzeri C, Tocco V, Pagani E, Bresin A, et al. Comprehensive analysis of PTEN status in Sezary syndrome. Blood. 2013;122:3511\u201320.","journal-title":"Blood"},{"key":"305_CR21","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1182\/blood-2007-06-095182","volume":"111","author":"M Marzec","year":"2008","unstructured":"Marzec M, Liu X, Kasprzycka M, Witkiewicz A, Raghunath PN, El-Salem M, et al. IL-2- and IL-15-induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+ T lymphocytes. Blood. 2008;111:2181\u20139.","journal-title":"Blood"},{"key":"305_CR22","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1111\/j.1600-0625.2010.01102.x","volume":"19","author":"M Kremer","year":"2010","unstructured":"Kremer M, Sliva K, Klemke C-D, Schnierle BS. Cutaneous T-cell lymphoma cells are sensitive to rapamycin. Exp Dermatol. 2010;19:800\u20135.","journal-title":"Exp Dermatol"},{"key":"305_CR23","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1182\/blood-2005-04-1492","volume":"107","author":"MG Narducci","year":"2006","unstructured":"Narducci MG, Scala E, Bresin A, Caprini E, Picchio MC, Remotti D, et al. Skin homing of S\u00e9zary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26\/dipeptidylpeptidase IV. Blood. 2006;107:1108\u201315.","journal-title":"Blood"},{"key":"305_CR24","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1126\/science.1106148","volume":"307","author":"DD Sarbassov","year":"2005","unstructured":"Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation and Regulation of Akt\/PKB by the Rictor-mTOR Complex. Science. 2005;307:1098\u2013101.","journal-title":"Science"},{"key":"305_CR25","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1158\/0008-5472.CAN-08-3014","volume":"69","author":"J Copp","year":"2009","unstructured":"Copp J, Manning G, Hunter T. TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for intact mTOR signaling complex 2. Cancer Res. 2009;69:1821\u20137.","journal-title":"Cancer Res"},{"key":"305_CR26","doi-asserted-by":"publisher","first-page":"7866","DOI":"10.1074\/jbc.M109.096222","volume":"285","author":"GA Soliman","year":"2010","unstructured":"Soliman GA, Acosta-Jaquez HA, Dunlop EA, Ekim B, Maj NE, Tee AR, et al. mTOR Ser-2481 Autophosphorylation Monitors mTORC-specific Catalytic Activity and Clarifies Rapamycin Mechanism of Action. J Biol Chem. 2010;285:7866\u201379.","journal-title":"J Biol Chem"},{"key":"305_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.it.2014.11.005","volume":"36","author":"KN Pollizzi","year":"2015","unstructured":"Pollizzi KN, Powell JD. Regulation of T cells by mTOR: the known knowns and the known unknowns. Trends Immunol. 2015;36:13\u201320.","journal-title":"Trends Immunol"},{"key":"305_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jdermsci.2013.12.003","volume":"74","author":"SCS Hu","year":"2014","unstructured":"Hu SC-S, Lin C-L, Hong C-H, Yu H-S, Chen G-S, Lee C-H. CCR7 expression correlates with subcutaneous involvement in mycosis fungoides skin lesions and promotes migration of mycosis fungoides cells (MyLa) through mTOR activation. J Dermatol Sci. 2014;74:31\u20138.","journal-title":"J Dermatol Sci"},{"key":"305_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.269","volume":"5","author":"C Ieran\u00f2","year":"2014","unstructured":"Ieran\u00f2 C, Santagata S, Napolitano M, Guardia F, Grimaldi A, Antignani E, et al. CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells. Cell Death Dis. 2014;5:e1310.","journal-title":"Cell Death Dis"},{"key":"305_CR30","doi-asserted-by":"publisher","first-page":"e24667","DOI":"10.1371\/journal.pone.0024667","volume":"6","author":"R Munk","year":"2011","unstructured":"Munk R, Ghosh P, Ghosh MC, Saito T, Xu M, Carter A, et al. Involvement of mTOR in CXCL12 mediated T cell signaling and migration. PLoS ONE. 2011;6:e24667.","journal-title":"PLoS ONE"},{"key":"305_CR31","first-page":"87","volume":"7","author":"DA Galloway","year":"2016","unstructured":"Galloway DA, Laimins LA, Division B, Hutchinson F. HHS Public Access. 2016;7:87\u201392.","journal-title":"HHS Public Access"},{"key":"305_CR32","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrm2672","volume":"10","author":"XM Ma","year":"2009","unstructured":"Ma XM, Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol. 2009;10:307\u201318.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"305_CR33","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.trecan.2017.04.002","volume":"3","author":"E Pons-Tostivint","year":"2017","unstructured":"Pons-Tostivint E, Thibault B, Guillermet-Guibert J. Targeting PI3K Signaling in Combination Cancer Therapy. Trends Cancer. 2017;3:454\u201369.","journal-title":"Trends Cancer"},{"key":"305_CR34","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/sj.emboj.7600110","volume":"23","author":"JM Lizcano","year":"2004","unstructured":"Lizcano JM, G\u00f6ransson O, Toth R, Deak M, Morrice NA, Boudeau J, et al. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK\/PAR-1. EMBO J. 2004;23:833\u201343.","journal-title":"EMBO J"},{"key":"305_CR35","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1053\/j.seminoncol.2015.09.009","volume":"43","author":"BM Heckman-Stoddard","year":"2016","unstructured":"Heckman-Stoddard BM, Gandini S, Puntoni M, Dunn BK, DeCensi A, Szabo E. Repurposing old drugs to chemoprevention: the case of metformin. Semin Oncol. 2016;43:123\u201333.","journal-title":"Semin Oncol"},{"key":"305_CR36","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.cmet.2010.03.014","volume":"11","author":"A Kalender","year":"2010","unstructured":"Kalender A, Selvaraj A, Kim SY, Gulati P, Br\u00fbl\u00e9 S, Viollet B, et al. Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner. Cell Metab. 2010;11:390\u2013401.","journal-title":"Cell Metab"},{"key":"305_CR37","doi-asserted-by":"publisher","first-page":"7137","DOI":"10.1158\/0008-5472.CAN-08-0602","volume":"68","author":"MC Picchio","year":"2008","unstructured":"Picchio MC, Scala E, Pomponi D, Caprini E, Frontani M, Angelucci I, et al. CXCL13 is highly produced by S\u00e9zary cells and enhances their migratory ability via a synergistic mechanism involving CCL19 and CCL21 chemokines. Cancer Res. 2008;68:7137\u201346.","journal-title":"Cancer Res"},{"key":"305_CR38","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1158\/1535-7163.MCT-12-1226-T","volume":"12","author":"M Cerezo","year":"2013","unstructured":"Cerezo M, Tichet M, Abbe P, Ohanna M, Lehraiki A, Rouaud F, et al. Metformin blocks melanoma invasion and metastasis development in AMPK\/p53-dependent manner. Mol Cancer Ther. 2013;12:1605\u201315.","journal-title":"Mol Cancer Ther"},{"key":"305_CR39","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1365-2133.2004.06325.x","volume":"152","author":"M Sokolowska-Wojdylo","year":"2005","unstructured":"Sokolowska-Wojdylo M, Wenzel J, Gaffal E, Lenz J, Speuser P, Erdmann S, et al. Circulating clonal CLA+ and CD4+ T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7. Br J Dermatol. 2005;152:258\u201364.","journal-title":"Br J Dermatol"},{"key":"305_CR40","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.ejca.2008.02.043","volume":"44","author":"I Hashimoto","year":"2008","unstructured":"Hashimoto I, Koizumi K, Tatematsu M, Minami T, Cho S, Takeno N, et al. Blocking on the CXCR4\/mTOR signalling pathway induces the anti-metastatic properties and autophagic cell death in peritoneal disseminated gastric cancer cells. Eur J Cancer. 2008;44:1022\u20139.","journal-title":"Eur J Cancer"},{"key":"305_CR41","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1182\/blood.V92.1.252.413k08_252_258","volume":"92","author":"U D\u00f6bbeling","year":"1998","unstructured":"D\u00f6bbeling U, Dummer R, Laine E, Potoczna N, Qin JZ, Burg G. Interleukin-15 is an autocrine\/paracrine viability factor for cutaneous T-cell lymphoma cells. Blood. 1998;92:252\u20138.","journal-title":"Blood"},{"key":"305_CR42","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1182\/blood.V57.3.452.452","volume":"57","author":"PA Bunn","year":"1981","unstructured":"Bunn PA, Edelson R, Ford SS, Shackney SE. Patterns of cell proliferation and cell migration in the S\u00e9zary syndrome. Blood. 1981;57:452\u201363.","journal-title":"Blood"},{"issue":"4","key":"305_CR43","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/hon.2900020406","volume":"2","author":"Johannes Gerdes","year":"1984","unstructured":"Gerdes J, Dallenbach F, Lennert K, Lemke H, Stein H. Growth fractions in malignant non-Hodgkin\u2019s lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67. Hematol Oncol.1984; 2: 365\u201371.","journal-title":"Hematological Oncology"},{"key":"305_CR44","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1038\/onc.2013.272","volume":"33","author":"L Borsig","year":"2014","unstructured":"Borsig L, Wolf MJ, Roblek M, Lorentzen A, Heikenwalder M. Inflammatory chemokines and metastasis\u2014tracing the accessory. Oncogene. 2014;33:3217\u201324.","journal-title":"Oncogene"},{"key":"305_CR45","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1038\/leu.2015.103","volume":"29","author":"K Fujii","year":"2015","unstructured":"Fujii K, Karpova MB, Asagoe K, Georgiev O, Dummer R, Urosevic-Maiwald M. Versican upregulation in S\u00e9zary cells alters growth, motility and resistance to chemotherapy. Leukemia. 2015;29:2024\u201332.","journal-title":"Leukemia"},{"key":"305_CR46","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ccr.2010.01.021","volume":"17","author":"AC Hsieh","year":"2010","unstructured":"Hsieh AC, Costa M, Zollo O, Davis C, Feldman ME, Testa JR, et al. Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E. Cancer Cell. 2010;17:249\u201361.","journal-title":"Cancer Cell"},{"key":"305_CR47","doi-asserted-by":"publisher","first-page":"5010","DOI":"10.4049\/jimmunol.164.10.5010","volume":"164","author":"T Nanki","year":"2018","unstructured":"Nanki T, Lipsky PE. T Cell Activation\u2009+\u2009Is a Costimulator for CD4 Cutting Edge: Stromal Cell-Derived Factor-1. J Immunol Ref. 2018;164:5010\u20134.","journal-title":"J Immunol Ref"},{"key":"305_CR48","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1182\/blood-2009-01-200923","volume":"114","author":"K Gollmer","year":"2009","unstructured":"Gollmer K, Asperti-Boursin F, Tanaka Y, Okkenhaug K, Vanhaesebroeck B, Peterson JR, et al. CCL21 mediates CD4+ T-cell costimulation via a DOCK2\/Rac-dependent pathway. Blood. 2009;114:580\u20138.","journal-title":"Blood"},{"key":"305_CR49","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1182\/blood-2017-03-772996","volume":"130","author":"M Roelens","year":"2017","unstructured":"Roelens M, Delord M, Ram-Wolff C, Marie-Cardine A, Alberdi A, Maki G, et al. Circulating and skin-derived S\u00e9zary cells: clonal but with phenotypic plasticity. Blood. 2017;130:1468\u201371.","journal-title":"Blood"},{"key":"305_CR50","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1053\/j.semdp.2016.11.002","volume":"34","author":"KSJ Elenitoba-Johnson","year":"2017","unstructured":"Elenitoba-Johnson KSJ, Wilcox R. A new molecular paradigm in mycosis fungoides and S\u00e9zary syndrome. Semin Diagn Pathol. 2017;34:15\u201321.","journal-title":"Semin Diagn Pathol"},{"key":"305_CR51","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s11899-016-0351-0","volume":"11","author":"R Kohnken","year":"2016","unstructured":"Kohnken R, Fabbro S, Hastings J, Porcu P, Mishra A. S\u00e9zary Syndrome: Clinical and Biological Aspects. Curr Hematol Malig Rep. 2016;11:468\u201379.","journal-title":"Curr Hematol Malig Rep"},{"key":"305_CR52","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.cell.2008.04.013","volume":"133","author":"L Salmena","year":"2008","unstructured":"Salmena L, Carracedo A, Pandolfi PP. Tenets of PTEN tumor suppression. Cell. 2008;133:403\u201314.","journal-title":"Cell"},{"key":"305_CR53","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.coi.2013.05.002","volume":"25","author":"H Zeng","year":"2013","unstructured":"Zeng H, Chi H. mTOR and lymphocyte metabolism. Curr Opin Immunol. 2013;25:347\u201355.","journal-title":"Curr Opin Immunol"},{"key":"305_CR54","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1038\/jid.2015.153","volume":"135","author":"W Kittipongdaja","year":"2015","unstructured":"Kittipongdaja W, Wu X, Garner J, Liu X, Komas SM, Hwang ST, et al. Rapamycin Suppresses Tumor Growth and Alters the Metabolic Phenotype in T-Cell Lymphoma. J Invest Dermatol. 2015;135:2301\u20138.","journal-title":"J Invest Dermatol"},{"key":"305_CR55","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1182\/blood-2014-07-590398","volume":"125","author":"LJ Geskin","year":"2015","unstructured":"Geskin LJ, Viragova S, Stolz DB, Fuschiotti P. Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation. Blood. 2015;125:2798\u2013805.","journal-title":"Blood"},{"key":"305_CR56","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1158\/1078-0432.CCR-16-1996","volume":"23","author":"T Wang","year":"2017","unstructured":"Wang T, Lu Y, Polk A, Chowdhury P, Zamalloa CM, Fujiwara H, et al. T-cell receptor signaling activates an ITK\/NF-\u03baB\/GATA-3 axis in T-cell lymphomas facilitating resistance to chemotherapy. Clin Cancer Res. 2017;23:2506\u201315.","journal-title":"Clin Cancer Res"},{"key":"305_CR57","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1182\/blood-2015-02-629543","volume":"126","author":"TE Witzig","year":"2015","unstructured":"Witzig TE, Reeder C, Han JJ, LaPlant B, Stenson M, Tun HW, et al. The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma. Blood. 2015;126:328\u201335.","journal-title":"Blood"},{"key":"305_CR58","doi-asserted-by":"publisher","first-page":"8097","DOI":"10.1158\/0008-5472.CAN-10-1814","volume":"70","author":"F Chiarini","year":"2010","unstructured":"Chiarini F, Grimaldi C, Ricci F, Tazzari PL, Evangelisti C. Activity of the novel dual phosphatidylinositol 3-kinase \/ mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemia activity of the novel dual phosphatidylinositol 3-kinase \/ mammalian target of rapamycin inhibitor NV. Cancer Res. 2010;70:8097\u2013107.","journal-title":"Cancer Res"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0305-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0305-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0305-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:36:12Z","timestamp":1684618572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-018-0305-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,5]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["305"],"URL":"https:\/\/doi.org\/10.1038\/s41375-018-0305-8","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,5]]},"assertion":[{"value":"27 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}